<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="article-commentary" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Epilepsy Curr</journal-id>
<journal-id journal-id-type="iso-abbrev">Epilepsy Curr</journal-id>
<journal-id journal-id-type="publisher-id">epcu</journal-id>
<journal-id journal-id-type="pmc">Epilepsy Curr</journal-id>
<journal-title-group>
<journal-title>Epilepsy Currents</journal-title>
</journal-title-group>
<issn pub-type="ppub">1535-7597</issn>
<issn pub-type="epub">1535-7511</issn>
<publisher>
<publisher-name>American Epilepsy Society</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28331464</article-id>
<article-id pub-id-type="pmc">5340549</article-id>
<article-id pub-id-type="doi">10.5698/1535-7511-17.1.16</article-id>
<article-id pub-id-type="sici">i1535-7511-17-1-16</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Current Review in Clinical Science</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>When Should Genetic Testing Be Performed in Epilepsy Patients?</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Poduri</surname>
<given-names>Annapurna</given-names>
</name>
<degrees>MD, MPH</degrees>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<aff id="aff1">Attending Physician/Director, Epilepsy Genetics Program, Boston Children's Hospital, Boston, MA</aff>
</contrib-group>
<author-notes>
<corresp id="cor1">Address correspondence to Annapurna Poduri, MD, MPH, Epilepsy Genetics Program, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA 02115. E-mail: <email>Annapurna.Poduri@childrens.harvard.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<season>Jan-Feb</season>
<year>2017</year>
</pub-date>
<volume>17</volume>
<issue>1</issue>
<fpage>16</fpage>
<lpage>22</lpage>
<permissions>
<copyright-statement>Â© American Epilepsy Society</copyright-statement>
<copyright-year>2017</copyright-year>
</permissions>
<abstract>
<p>This review is a summary of a talk presented at the 2015 American Epilepsy Society Annual Meeting. Its purposes are 1) to review developments in epilepsy genetics, 2) to discuss which groups of patients with epilepsy might benefit from genetic testing, and 3) to present a rational approach to genetic testing in epilepsy in the rapidly evolving era of genomic medicine.</p>
</abstract>
<counts>
<page-count count="7"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>